# Gaudi Clinical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gaudi-clinical

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.gaudi-clinical.co.jp
- Total disclosed funding: $11M
- Latest round: Series A (Feb 7, 2025)
- Investors on record: 8

## About

Founded in 2021 and based in Tokyo, Japan, Gaudi Clinical operates as a producer of cultivated cells used in regenerative medicine for the dentistry and orthopedic fields. In April 2025, Gaudi Clinical raised an undisclosed amount in venture funding from new investor Sysmex. The firm as of February 2025, is led by its President and CEO, Mamoru Tobita. Gaudi Clinical specializes in advanced regenerative medicine solutions, focusing on autologous PRP (Platelet-Rich Plasma) therapies and Adult Stem Cells (ASCs). These treatments are aimed at enhancing healing processes in surgical environments and improving patient outcomes, catering to healthcare providers, hospitals, and research institutions both in Japan and potentially in other Asian markets. Their products are presented at key industry conferences, highlighting their commitment to medical innovation. Gaudi Clinical operates on a B2B model, engaging healthcare institutions and professionals in the procurement of their regenerative medicine products. Revenue is generated through transactions for individual therapies and potential subscriptions within medical networks, facilitating ongoing support for their offerings. The company plans to use the April 2025 funding to continue the development of its products and services for regenerative medicine.

## Funding rounds

- Series A, Feb 7, 2025, $8.9M — JAFCO Group, Mitsui Sumitomo Insurance Venture Capital, Mizuho Capital, Shizuoka Capital, Samurai Incubate, KISCO, JIC Venture Growth Investments, Future Creation Capital
- Seed, Nov 22, 2022, $2.6M — JAFCO Group

## Investors

- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Seed, Series A
- Mitsui Sumitomo Insurance Venture Capital (https://capitalatlas.ai/funds/mitsui-sumitomo-insurance-venture-capital) — Series A
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Shizuoka Capital (https://capitalatlas.ai/funds/shizuoka-capital) — Series A
- Samurai Incubate (https://capitalatlas.ai/funds/samurai-incubate) — Series A
- KISCO — Series A
- JIC Venture Growth Investments (https://capitalatlas.ai/funds/jic-venture-growth-investments) — Series A
- Future Creation Capital (https://capitalatlas.ai/funds/future-creation-capital) — Series A